Previous 10 | Next 10 |
Eastman Kodak (NYSE: KODK ) +44% on D.E.Shaw stake . More news on: Eastman Kodak Company, Priority Technology Holdings, Inc., Zoom Video Communications, Inc., Stocks on the move, , Read more ...
Looking For high Volume Penny Stocks Today? Check Out These 3 If you were looking at some of the penny stocks today, what were you looking at? Were you focused on headlines? Were you looking for disclosure statements? Maybe you were interested in upcoming results or earnings. On the other ha...
The FDA has signed off on emergency use of T2 Biosystems' (NASDAQ: TTOO ) T2SARS-CoV-2 Panel, a molecular test that detects the presence of the coronavirus in a nasopharyngeal sample in less than two hours. More news on: T2 Biosystems, Inc., Healthcare stocks news, Stocks on the move, ...
LEXINGTON, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its COVID-19 molecular d...
Top 3 Convalescent Plasma Stocks To Watch Before September 2020 There’s no doubt biotech stocks have been grabbing headlines since the novel coronavirus outbreak this year. Specifically, top biotech stocks to buy this year such as Novavax ( NVAX Stock Report ) and Moderna ( MRNA Sto...
Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +67% on FDA nod for convalescent plasma. More news on: Sonnet BioTherapeutics Holdings, Inc., Liminal BioSciences Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...
Convalescent Plasma Stocks To Watch Penny stocks shift in an instant and that could be the case for a few companies this week. Over the weekend, U.S. President Donald Trump announced the emergency authorization of convalescent plasma for COVID-19. At a press briefing that began at 5:30 PM ES...
T2 ( TTOO ), one of the stocks that I have followed for my speculative biotech portfolio, has been on the emergency floor for a while. I consider it as being in the danger zone because it is struggling to commercialize its suite of FDA approved testing devices as I describe below. T2's new C...
T2 Biosystems, Inc. (TTOO) Q2 2020 Earnings Conference Call August 11, 2020 04:30 PM ET Company Participants Philip Taylor - Investor Relations John Sperzel - President & Chief Executive Officer John Sprague - Chief Financial Officer Tom Lowery - Chief Scientific Officer ...
T2 Biosystems (NASDAQ: TTOO ) : Q2 GAAP EPS of -$0.09 beats by $0.05 . Revenue of $2.55M (+41.7% Y/Y) in-line. Total cash, cash equivalents and marketable securities of $35.8M. Shares -2.7% . Press Release More news on: T2 Biosystems, Inc., Earnings news and commentary, Health...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial and operational results for the second quarter ended Jun...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Malaysia and Indonesia. Under the ter...
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2024 and business updates after mar...